MedPath

Acetate

Generic Name
Acetate
Drug Type
Small Molecule
Chemical Formula
C2H3O2
CAS Number
71-50-1
Unique Ingredient Identifier
569DQM74SC
Clinical Trials
Related News

Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.

Phase 3
Completed
Conditions
Cataract
Interventions
First Posted Date
2011-11-21
Last Posted Date
2019-06-11
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
107
Registration Number
NCT01475643
Locations
🇺🇸

Bausch & Lomb Inc, Rochester, New York, United States

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

Phase 4
Completed
Conditions
Postpartum Depression
Lactation
Contraception
Interventions
First Posted Date
2011-11-01
Last Posted Date
2018-08-31
Lead Sponsor
Beatrice Chen
Target Recruit Count
184
Registration Number
NCT01463202
Locations
🇺🇸

Center for Family Planning Research, Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

Phase 2
Completed
Conditions
Heavy Uterine Bleeding
Uterine Fibroids
Interventions
Drug: Placebo
First Posted Date
2011-09-28
Last Posted Date
2021-07-13
Lead Sponsor
AbbVie (prior sponsor, Abbott)
Target Recruit Count
271
Registration Number
NCT01441635

Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use

Phase 1
Completed
Conditions
HIV Prevention
Interventions
First Posted Date
2011-08-22
Last Posted Date
2015-04-10
Lead Sponsor
CONRAD
Target Recruit Count
72
Registration Number
NCT01421368
Locations
🇺🇸

University of Pittsburgh School of Medicine, Center for Family Planning Research, Pittsburgh, Pennsylvania, United States

🇺🇸

Easter Virginia Medical School, Norfolk, Virginia, United States

🇩🇴

Profamilia, Santo Domingo, Dominican Republic

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2011-02-25
Last Posted Date
2019-03-07
Lead Sponsor
Phoenix Molecular Imaging
Target Recruit Count
2000
Registration Number
NCT01304485
Locations
🇺🇸

Phoenix Molecular Imaging, Phoenix, Arizona, United States

Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women

Phase 2
Completed
Conditions
HIV-1 Infection
Interventions
First Posted Date
2011-02-15
Last Posted Date
2015-12-22
Lead Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Target Recruit Count
25
Registration Number
NCT01296152
Locations
🇺🇸

Rush University Cook County Hospital Chicago NICHD CRS (5083), Chicago, Illinois, United States

🇺🇸

SUNY Stony Brook NICHD CRS (5040), Stony Brook, New York, United States

🇺🇸

University of Washington AIDS CRS (1401), Seattle, Washington, United States

and more 11 locations

Acid-base Balance in Patients Undergoing Colonoscopy

Phase 1
Conditions
Colonoscopy
Bowel Preparation
Interventions
Drug: Normal saline solution
Drug: Lactated Ringer's solution
First Posted Date
2010-12-01
Last Posted Date
2016-03-16
Lead Sponsor
Mahidol University
Target Recruit Count
90
Registration Number
NCT01250886

Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi

Not Applicable
Completed
Conditions
HIV
Interventions
First Posted Date
2010-08-30
Last Posted Date
2013-10-25
Lead Sponsor
Emory University
Target Recruit Count
200
Registration Number
NCT01191203
Locations
🇲🇼

The Lighthouse Trust, Lilongwe, Malawi

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Activella®
First Posted Date
2010-08-13
Last Posted Date
2010-12-08
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
40
Registration Number
NCT01181726
Locations
🇨🇦

Biovail Contract Research, Toronto, Ontario, Canada

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Activella®
First Posted Date
2010-07-05
Last Posted Date
2010-12-17
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
36
Registration Number
NCT01157182
Locations
🇨🇦

Biovail Clinical Research, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy